bio-techne.com - TECH Total Company Value-to-Revenue Ratio

Bio-Techne Corp (TECH) - corporate logo

Bio-Techne Corporation (TECH) ensures supply stability through its decentralized network of plants, which supports the current enterprise value-to-revenue multiple. The value 9246.13 reflects the status of the business valuation parameter. High margins and capacities across the US and Europe guarantee resilience, while the reagent ecosystem creates strong customer retention through scientific publications and FDA-supervised M&A.

Techne Corporation (TECH) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for Techne Corporation (TECH)

- share price and consensus valuation forecast:
Fundamental company valuation:TECH, bio-techne.com
Flagship merchandise of Bio-Techne Corp

Bio-Techne Corporation (TECH) maintains a diversified portfolio of reagents and proteins that ensures a stable revenue stream, allowing the use of the enterprise value-to-sales ratio to gauge market confidence in the company's resilience. By analyzing the EV/Sales metric of Bio-Techne Corporation (TECH), an investor can view the enterprise value net of debt relative to turnover, which objectifies the fundamental attractiveness of the assets regardless of financial leverage.